Blosozumab (Anti-SOST / Sclerostin)

Blosozumab (anti-SOST/ Sclerostin) is a humanized monoclonal antibody against sclerostin. Blosozumab stimulates bone formation, reduces bone resorption, and has the potential to be used in the research of osteoporosis. MW: 144.88 kD.

• Supplier: Selleck Chemicals
• Product #: A2787
• Sku #: A2787-1mg